Acasti Pharma reported $17.3M in Current Assets for its fiscal quarter ending in September of 2025.





Current Assets Change Date
Acasti Pharma USD 17.3M 3.22M Sep/2025
Addus HomeCare USD 260.66M 2.38M Sep/2025
Amarin USD 628.33M 21.52M Sep/2025
Cassava Sciences USD 108.91M 5.91M Sep/2025
Knight Therapeutics CAD 397.57M 36.96M Sep/2024
Option Care Health USD 1.28B 107.54M Sep/2025
Organigram Holdings CAD 284.9M 7.11M Sep/2025
Tilray USD 688.63M 2.34M Mar/2025